|
Aerosol Treatment Chambers
While the largest
amount of filtration business in a healthcare facility is
typically found within the air handling system, there are
many unique applications where filtration is used as part of
a diagnostic or medical treatment procedure. One of these
applications is the aerosol treatment chamber.
An aerosol treatment
chamber or booth is a negative pressure mini-environment
that has HEPA filtered exhaust. The booth is maintained
under negative pressure in order to prevent harmful airborne
pathogens or treatment aerosols from being introduced into
the facility. These booths are often provided with a
pressure monitor that continually shows the pressure status
of the booth and has an audible alarm to alert workers if
the negative pressure is ever compromised.
A patient sits in
the chamber during the administration of an aerosol used for
diagnostic analysis or therapeutic treatment. The most
common applications for aerosol treatment chambers are
sputum induction procedures and aerosolized pentamidine
treatments.
Pentamidine
treatments: Pentamidine is an aerosol that may be
used in the treatment of immune compromised pneumonia
patients. This aerosol though, may adversely affect the
health of caregivers if there is repeated exposure over a
pro-longed period of time. To reduce the risk to staff,
these treatments are normally given to patients inside an
aerosol treatment chamber or a negative pressure isolation
room.
Sputum Induction:
Sputum induction is typically performed on patients to
confirm or rule out a diagnosis of active TB disease. It is
used to obtain sputum for diagnostic purposes when patients
are unable to spontaneously expectorate a specimen. The
procedure uses sterile water or hypertonic saline to
irritate the airway, increase secretions, promote coughing,
and produce a specimen. The CDC and the Occupational Safety
and Health Administration (OSHA) both classify sputum
induction as a high-risk procedure when performed on a
suspected or known infectious TB patient. This
procedure induces coughing, resulting in a greater
likelihood that infectious droplet nuclei are expelled into
room air.1
Performing
a sputum induction in an aerosol treatment chamber with HEPA
filtered exhaust, instead of a negative pressure room may
provide increased protection for the healthcare worker
administering the test. This eliminates the need for the
healthcare worker to wear a respirator during the procedure.2
The HEPA filtered
exhaust from the booth or chamber may be discharged back
into the room or exhausted to the outside.3 If
the exhaust air is discharged into the room, a HEPA filter
should be incorporated at the discharge duct or vent of the
device. The exhaust fan should be located on the discharge
side of the HEPA filter to ensure that the air pressure in
the filter housing and booth is negative with respect to
adjacent areas. Uncontaminated air from the room will flow
into the booth through all openings, thus preventing
infectious droplet nuclei in the booth from escaping into
the room.4
The
HEPA filters on these enclosures should have appropriate
pre-filtration and should be changed when the enclosure is
no longer able to maintain negative pressure or provide a
minimum of 12 air changes per hour of HEPA filtered exhaust.
When changing the filters the maintenance person should wear
N-95 respirators and gloves.5 The filter should
be handled gently and sealed into a plastic bag after
removal. The CDC does not recommend red bagging of these
filters, stating that disposal in normal trash6
is appropriate. Local and state codes should be consulted
though, as they may differ.
References:
1,
2, 3 Francis J. Curry National Tuberculosis Center,
Institutional Consultation Services. Conducting Sputum
Induction Safely. 1999.
4,
5 Guidelines for Preventing the Transmission of
Mycobacterium tuberculosis in Health-Care Settings 2005
(Draft) Department of
Health
and Human Services, Centers for Disease Control and
Prevention.
6
Guidelines for Environmental Infection Control in
Health-Care Facilities. Recommendations of CDC and the
Healthcare Infection Control Practices Advisory Committee (HICPAC)
2003.
|